David Penn, Ph.D.
Professor and Associate Director of Clinical Psychology

Home

Research

Lab Members

Resource Links


UNC-CH
Department of Psychology
250 Davie Hall
Chapel Hill, NC 27599-3270

Phone: 919-843-7514
Fax: 919--962-2537
e-mail: dpenn@email.unc.edu

RESEARCH

 

CURRENT STUDIES

Social Cognition and Functioning (SCAF)
PI:Michael Green, Ph.D.; Site PI: David Penn, Ph.D.
Funded by: NIH

The purpose of this study is to determine the extent to which selected measures from social neuroscience are suitable for use in clinical trials of schizophrenia. We are investigating whether these measures can account for unexplained variance in functioning and and wish to better understand the ways in which social cognition acts as a mediator between basic (non-social) cognition and functioning in schizophrenia.

Click here to learn more about SCAF

******************************************

Social Cognition Psychometric Evaluation (SCOPE)
PI: Philip Harvey, Ph.D., David Penn, Ph.D. and Amy Pinkham, Ph.D.
Funded by: NIMH

The purpose of this study is to examine the current psychometric properties of the selected social cognition measures for individuals with schizophrenia . A sub-study of SCOPE is the Evaluation of Social Cognition Assessment in Early Psychosis (ESCAEP), which focuses on social cognition in individuals with first episode psychosis .

Click here to learn more about SCOPE or ESCAEP

******************************************


Oxytocin Treatment of Social Deficits and Paranoia in Schizophrenia (OTS)
PI: Cort Pedersen, M.D., David Penn, Ph.D.
Co-I: Robert Hamer, Ph.D., Shane Rau, M.D., Ph.D., Fred Jarskog, M.D.
Funded by: NIMH

The purpose of this study is to compare the effects of 12 weeks of twice daily intranasal administration of Oxytocin versus placebo on difficulties in social relationships, social functioning, and other psychotic symptoms.

Click here to learn more about OTS

******************************************


Recovery After an Initital Schizophrenia Episode (RAISE)
PI: John Kane, M.D., UNC Site PI: David Penn, Ph.D.
Funded by: NIMH

RAISE is a multi-site randomized clinical trial, funded by National Institute of Mental Health, to evaluate the benefits of two years of a comprehensive pharmacological and psychosocial treatment package (the RAISE Enhanced Treatment Program) for individuals  with first episode psychosis compared to usual community mental health treatment (community care).

Click here to learn more about RAISE

******************************************

 

Click here to see recent student dissertations

Click here to see recent student masters theses

back to top